1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Blood and immune system conditions
  5. Blood and bone marrow cancers

Mogamulizumab for previously treated mycosis fungoides and Sézary syndrome

Technology appraisal guidance [TA754] Published: 15 December 2021

  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Evidence

Review and download supporting evidence. Includes the full guideline if available.

Supporting evidence

  • Evaluation report  
  • Appraisal consultation committee papers PDF 6.36 MB 15 December 2021  
  • Final appraisal determination 1 committee papers PDF 1.48 MB 15 December 2021  
  • Final appraisal determination 2 committee papers PDF 1.4 MB 15 December 2021